Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 5
2005 1
2006 2
2007 6
2008 2
2009 7
2010 9
2011 4
2012 1
2013 2
2014 5
2015 1
2017 1
2018 4
2019 5
2020 1
2021 7
2022 6
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
IL-1 Family Members in Bone Sarcomas.
Landuzzi L, Ruzzi F, Pellegrini E, Lollini PL, Scotlandi K, Manara MC. Landuzzi L, et al. Cells. 2024 Jan 25;13(3):233. doi: 10.3390/cells13030233. Cells. 2024. PMID: 38334625 Free PMC article. Review.
Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages.
Manara MC, Manferdini C, Cristalli C, Carrabotta M, Santi S, De Feo A, Caldoni G, Pasello M, Landuzzi L, Lollini PL, Salamanna F, Dominici S, Fiori V, Magnani M, Lisignoli G, Scotlandi K. Manara MC, et al. Among authors: landuzzi l. Cancer Immunol Res. 2024 Feb 2;12(2):247-260. doi: 10.1158/2326-6066.CIR-23-0440. Cancer Immunol Res. 2024. PMID: 38051221 Free PMC article.
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC.
Ruzzi F, Angelicola S, Landuzzi L, Nironi E, Semprini MS, Scalambra L, Altimari A, Gruppioni E, Fiorentino M, Giunchi F, Ferracin M, Astolfi A, Indio V, Ardizzoni A, Gelsomino F, Nanni P, Lollini PL, Palladini A. Ruzzi F, et al. Among authors: landuzzi l. Transl Lung Cancer Res. 2022 Nov;11(11):2216-2229. doi: 10.21037/tlcr-22-163. Transl Lung Cancer Res. 2022. PMID: 36519016 Free PMC article.
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine.
Ruzzi F, Palladini A, Clemmensen S, Strøbæk A, Buijs N, Domeyer T, Dorosz J, Soroka V, Grzadziela D, Rasmussen CJ, Nielsen IB, Soegaard M, Semprini MS, Scalambra L, Angelicola S, Landuzzi L, Lollini PL, Thorn M. Ruzzi F, et al. Among authors: landuzzi l. Biomedicines. 2022 Oct 20;10(10):2654. doi: 10.3390/biomedicines10102654. Biomedicines. 2022. PMID: 36289916 Free PMC article.
Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma.
Chiarini F, Paganelli F, Balestra T, Capanni C, Fazio A, Manara MC, Landuzzi L, Petrini S, Evangelisti C, Lollini PL, Martelli AM, Lattanzi G, Scotlandi K. Chiarini F, et al. Among authors: landuzzi l. Cell Death Dis. 2022 Apr 14;13(4):346. doi: 10.1038/s41419-022-04729-5. Cell Death Dis. 2022. PMID: 35422060 Free PMC article.
Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma.
Carrabotta M, Laginestra MA, Durante G, Mancarella C, Landuzzi L, Parra A, Ruzzi F, Toracchio L, De Feo A, Giusti V, Pasello M, Righi A, Lollini PL, Palmerini E, Donati DM, Manara MC, Scotlandi K. Carrabotta M, et al. Among authors: landuzzi l. Cancer Res. 2022 Feb 15;82(4):708-720. doi: 10.1158/0008-5472.CAN-21-1222. Cancer Res. 2022. PMID: 34903601 Free PMC article.
74 results